Literature DB >> 22963396

Clinical and laboratory findings in patients with oliguric and non-oliguric hantavirus haemorrhagic fever with renal syndrome: an analysis of 128 patients.

D Turčinov1, I Puljiz, A Markotić, I Kuzman, J Begovac.   

Abstract

Patients with haemorrhagic fever with renal syndrome (HFRS) may present without significant oliguria. We compared different initial clinical symptoms and laboratory findings in patients who developed oliguric acute renal failure (ARF) with those in patients who did not develop oliguric ARF. Overall, 128 patients with serologically confirmed HFRS were hospitalized at the University Hospital for Infectious Disease, Zagreb, Croatia between January 1999 and December 2010. Clinical signs and laboratory findings were extracted from medical charts, and were assessed for their relationship to the development of oliguric ARF. Puumala virus infection was diagnosed in 101 (79%) patients, and Dobrava-Belgrade virus infection in 27 (21%). Oliguria or anuria developed in 30% of patients. We identified the following risk factors for the development of oliguria and anuria on multivariable analysis: conjunctival hyperaemia or bleeding (relative risk (RR) 1.84, 95% CI 1.09-3.10; p 0.023), diarrhoea (RR 1.45, 95% CI 1.07-1.97; p 0.017), serum sodium of ≤133 mM (RR 2.21, 95% CI 1.34-3.64; p 0.002), and dipstick protein value of >1.5 g/L (RR 1.59, 95% CI 1.09-2.33; p 0.016), as well as hiking in the forest (RR 1.92, 95% CI 1.13-3.26; p 0.016). Our findings may help physicians in the earlier identification of patients with a more severe form of HFRS caused by Puumala and Dobrava-Belgrade viruses. Particular attention should be given to findings such as conjunctival hyperaemia or bleeding, diarrhoea, a low serum sodium level, and proteinuria.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22963396     DOI: 10.1111/j.1469-0691.2012.03994.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Severe thrombocytopenia in hantavirus-induced nephropathia epidemica.

Authors:  J Latus; D Kitterer; S Segerer; F Artunc; M D Alscher; N Braun
Journal:  Infection       Date:  2014-11-08       Impact factor: 3.553

Review 2.  The kidney in hantavirus infection-epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management.

Authors:  Felix C Koehler; Veronica Di Cristanziano; Martin R Späth; K Johanna R Hoyer-Allo; Manuel Wanken; Roman-Ulrich Müller; Volker Burst
Journal:  Clin Kidney J       Date:  2022-01-29

3.  Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, Germany.

Authors:  Joerg Latus; Matthias Schwab; Evelina Tacconelli; Friedrich-Michael Pieper; Daniel Wegener; Juergen Dippon; Simon Müller; David Zakim; Stephan Segerer; Daniel Kitterer; Martin Priwitzer; Barbara Mezger; Birgit Walter-Frank; Angela Corea; Albrecht Wiedenmann; Stefan Brockmann; Christoph Pöhlmann; M Dominik Alscher; Niko Braun
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

4.  Urinary Clusterin Is Upregulated in Nephropathia Epidemica.

Authors:  Ekaterina V Martynova; Adelya N Maksudova; Venera G Shakirova; Sayar R Abdulkhakov; Ilsiyar M Khaertynova; Vladimir A Anokhin; Vilena V Ivanova; Ilesanmi M Abiola; Ekaterina E Garanina; Leisan G Tazetdinova; Aigul H Valiullina; Svetlana F Khaiboullina
Journal:  Dis Markers       Date:  2018-02-26       Impact factor: 3.434

5.  Sequential assessment of clinical and laboratory parameters in patients with hemorrhagic fever with renal syndrome.

Authors:  Emil Pal; Miša Korva; Katarina Resman Rus; Nataša Kejžar; Petra Bogovič; Anica Kurent; Tatjana Avšič-Županc; Franc Strle
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

6.  Proteinuria and the Clinical Course of Dobrava-Belgrade Hantavirus Infection.

Authors:  Markus Meier; Jan Kramer; Wolfram J Jabs; Claudia Nolte; Jörg Hofmann; Detlev H Krüger; Hendrik Lehnert; Martin Nitschke
Journal:  Nephron Extra       Date:  2018-02-09

7.  Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission.

Authors:  Maxime Hentzien; Stéphanie Mestrallet; Pascale Halin; Laure-Anne Pannet; Delphine Lebrun; Moustapha Dramé; Firouzé Bani-Sadr; Jean-Marc Galempoix; Christophe Strady; Jean-Marc Reynes; Christian Penalba; Amélie Servettaz
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

8.  Serum Cytokine Alterations Associated with Age of Patients with Nephropathia Epidemica.

Authors:  Venera Shakirova; Ilseyar Khaertynova; Maria Markelova; Rachael Tarlinton; Jerzy Behnke; Ekaterina Martynova; Ekaterina Garanina; Albert Rizvanov; Svetlana Khaiboullina
Journal:  Biomed Res Int       Date:  2022-01-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.